This inventor holds 1 USPTO granted patent. Top assignees: Daegu-Gyeongbuk Medical Innovation Foundation, Immunoforge Co., Ltd.. Active years: 2026.
Company Filing History:
1 out of 10 
1 out of 1 Years Active: 2026
Title: Heegyum Moon: Innovator in Cancer Treatment
Introduction
Heegyum Moon is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatment methods. His innovative work has led to the creation of a unique compound that shows promise in inhibiting cancer cell proliferation.
Latest Patents
Heegyum Moon holds a patent for a compound titled "3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethinyl)-N-phenylbenzamide derivative." This invention includes a method for preparing the compound and a pharmaceutical composition that utilizes it as an active ingredient for the prevention or treatment of cancer. The derivative is particularly effective in inhibiting kinases, especially Bcr-Abl kinase or Bcr-Abl (T315I) kinase, making it a valuable asset in cancer therapy.
Career Highlights
Throughout his career, Heegyum Moon has been associated with prominent organizations such as the Daegu-Gyeongbuk Medical Innovation Foundation and Immunoforge Co., Ltd. His work in these institutions has allowed him to advance his research and contribute to the medical field significantly.
Collaborations
Heegyum Moon has collaborated with talented individuals, including Doohyun Lee and Seungyeon Lee. These partnerships have fostered a collaborative environment that enhances innovation and research in cancer treatment.
Conclusion
Heegyum Moon's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work not only showcases his expertise but also holds the potential to impact the lives of many individuals affected by cancer.